1. Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus

   • Peter H. Jones
   • Kenneth Cusi
   • C. Stolzenbach

   Original Research Article 17 August 2012 Pages: 73 - 84

   

2. Predictors of Annual Pharmaceutical Costs in Australia for Community-Based Individuals with, or at Risk of, Cardiovascular Disease

   • Zanfina Ademi
   • Danny Liew
   • Christopher M. Reid

   Original Research Article 17 August 2012 Pages: 85 - 94

   

3. Preservation of Bioavailability of Ingredients and Lack of Drug-Drug Interactions in a Novel Five-Ingredient Polypill (Polycap™)

   • Anil Patel
   • Tarang Shah
   • Bhaswat S. Chakraborty

   Original Research Article 17 August 2012 Pages: 95 - 103

   

4. Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia

   • Megan N. Willson
   • Joshua J. Neumiller
   • Tracy L. Skaer

   Short Communication 17 August 2012 Pages: 105 - 108

   

5. Extent of Control of Cardiovascular Risk Factors and Adherence to Recommended Therapies in US Multiethnic Adults with Coronary Heart Disease

   • Dusko Vulic
   • Brian T. Lee
   • Nathan D. Wong

   Short Communication 17 August 2012 Pages: 109 - 114

   

6. Heterogeneity of Efficacy and Safety of Antiplatelet Therapy in Cardiovascular and Cerebrovascular Disease

   • James M. Gebel

   Review Article 17 August 2012 Pages: 115 - 124

   

7. Low-Dose Aspirin Therapy for Cardiovascular Prevention

   • Johan Herlitz
   • Peter P. Tóth
   • Jørgen Næsdal

   Review Article 17 August 2012 Pages: 125 - 141